Search Results

Wild life

• Authors : Wei, Opal

Record details

Surgical treatment and outcome of primary rib tumours in cats: eight cases (2016-2023).

• Authors : Cinti F; Surgery Department, San Marco Veterinary Clinic and Laboratory, Veggiano, Italy.; Martano M

Subjects: Cat Diseases*/Cat Diseases*/Cat Diseases*/surgery ; Bone Neoplasms*/Bone Neoplasms*/Bone Neoplasms*/veterinary ; Bone Neoplasms*/Bone Neoplasms*/Bone Neoplasms*/surgery

• Source: The Journal of small animal practice [J Small Anim Pract] 2024 Nov; Vol. 65 (11), pp. 822-829. Date of Electronic Publication: 2024 Aug 07.Publisher: Blackwell Scientific Publications Country of Publication: England NLM ID: 0165053 Publication Model: Print-Electronic Cited Medium: Internet

Record details

A deep learning model to enhance the classification of primary bone tumors based on incomplete multimodal images in X-ray, CT, and MRI.

• Authors : Song L; Department of Radiology, The Third Affiliated Hospital, Southern Medical University (Academy of Orthopedics, Guangdong Province), Guangzhou, Guangdong, China.; Li C

Subjects: Deep Learning* ; Bone Neoplasms*/Bone Neoplasms*/Bone Neoplasms*/diagnostic imaging ; Bone Neoplasms*/Bone Neoplasms*/Bone Neoplasms*/classification

• Source: Cancer imaging : the official publication of the International Cancer Imaging Society [Cancer Imaging] 2024 Oct 10; Vol. 24 (1), pp. 135. Date of Electronic Publication: 2024 Oct Publisher: Springer Nature Country of Publication: England NLM ID: 101172931 Publication Model: Electronic Cited Medium: Internet ISSN: 1470-7330

Record details

Liu-Shen-Wan inhibits PI3K/Akt and TRPV1 signaling alleviating bone cancer pain in rats.

• Authors : Zhang H; Department of Oncology, Guangdong Provincial Hospital of Traditional Chinese Medicine, Hainan Hospital, Haikou, Hainan, China.; Jiang J

Subjects: TRPV Cation Channels*/TRPV Cation Channels*/TRPV Cation Channels*/metabolism ; TRPV Cation Channels*/TRPV Cation Channels*/TRPV Cation Channels*/antagonists & inhibitors ; Bone Neoplasms*/Bone Neoplasms*/Bone Neoplasms*/drug therapy

• Source: Cancer biology & therapy [Cancer Biol Ther] 2024 Dec 31; Vol. 25 (1), pp. 2432098. Date of Electronic Publication: 2024 Nov 25.Publisher: Taylor & Francis Country of Publication: United States NLM ID: 101137842 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Identification of UNC5B as a novel aggressive biomarker for osteosarcoma based on basement membrane genes.

• Authors : Pan R; Department of Sports Medicine, The First Affiliated Hospital, Guangdong Provincial Key Laboratory of Speed Capability, The Guangzhou Key Laboratory of Precision Orthopedics and Regenerative Medicine, Jinan University, Guangzhou, China.; Zhang Y

Subjects: Osteosarcoma*/Osteosarcoma*/Osteosarcoma*/genetics ; Osteosarcoma*/Osteosarcoma*/Osteosarcoma*/pathology ; Biomarkers, Tumor*/Biomarkers, Tumor*/Biomarkers, Tumor*/genetics

• Source: Gene [Gene] 2024 Dec 20; Vol. 930, pp. 148871. Date of Electronic Publication: 2024 Aug 19.Publisher: Elsevier/North-Holland Country of Publication: Netherlands NLM ID: 7706761 Publication Model: Print-Electronic Cited Medium: Internet

Record details

Large-Scale Comparative Analysis of Canine and Human Osteosarcomas Uncovers Conserved Clinically Relevant Tumor Microenvironment Subtypes.

• Authors : Patkar S; Artificial Intelligence Resource, Molecular Imaging Branch, National Cancer Institute, NIH, Bethesda, Maryland.; Mannheimer J

Subjects: Osteosarcoma*/Osteosarcoma*/Osteosarcoma*/genetics ; Osteosarcoma*/Osteosarcoma*/Osteosarcoma*/veterinary ; Osteosarcoma*/Osteosarcoma*/Osteosarcoma*/pathology

• Source: Clinical cancer research : an official journal of the American Association for Cancer Research [Clin Cancer Res] 2024 Dec 16; Vol. 30 (24), pp. 5630-5642.Publisher: American Association for Cancer Research Country of Publication: United States NLM ID: 9502500 Publication Model: Print Cited Medium:

Record details

Inhibition of discoidin domain receptor 1 as a new therapeutic strategy for osteosarcoma.

• Authors : Wang J; Department of Obstetrics and Gynecology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan, China.; Walker RL

Subjects: Osteosarcoma*/Osteosarcoma*/Osteosarcoma*/metabolism ; Osteosarcoma*/Osteosarcoma*/Osteosarcoma*/pathology ; Osteosarcoma*/Osteosarcoma*/Osteosarcoma*/genetics

• Source: FASEB journal : official publication of the Federation of American Societies for Experimental Biology [FASEB J] 2024 Dec 15; Vol. 38 (23), pp. e70239.Publisher: Federation of American Societies for Experimental Biology Country of Publication: United States NLM ID: 8804484 Publication Model: Print Cited

Record details

Disulfidoptosis-related molecular subtypes and prognostic model for optimizing drug therapy in metastatic osteosarcoma patients.

• Authors : Wang X; Department of Joint and Orthopedics, Zhujiang Hospital, Southern Medical University, Guangzhou, Guangdong, P.R. China.; Department of Orthopedics, Zhongshan Xiaolan People's Hospital (The Fifth People's Hospital of Zhongshan), Zhongshan, Guangdong, China.

Subjects: Osteosarcoma*/Osteosarcoma*/Osteosarcoma*/drug therapy ; Osteosarcoma*/Osteosarcoma*/Osteosarcoma*/genetics ; Osteosarcoma*/Osteosarcoma*/Osteosarcoma*/pathology

• Source: FASEB journal : official publication of the Federation of American Societies for Experimental Biology [FASEB J] 2024 Dec 13; Vol. 38 (24), pp. e70258.Publisher: Federation of American Societies for Experimental Biology Country of Publication: United States NLM ID: 8804484 Publication Model: Print Cited

Record details

Establishment and characterization of NCC-GCTB10-C1: a novel cell line derived from a patient with recurrent giant cell tumor of bone.

• Authors : Adachi Y; Division of Rare Cancer Research, National Cancer Center Research Institute, 5-1-1 Tsukiji, Chuo-Ku, Tokyo, 104-0045, Japan.; Division of Hepato-Biliary-Pancreatic Surgery and Transplant Surgery, Department of Surgery, Asahikawa Medical University, 2-1-1 Midorigaoka Higashi, Asahikawa, Hokkaido, Japan.

Subjects: Giant Cell Tumor of Bone*/Giant Cell Tumor of Bone*/Giant Cell Tumor of Bone*/pathology ; Giant Cell Tumor of Bone*/Giant Cell Tumor of Bone*/Giant Cell Tumor of Bone*/genetics ; Bone Neoplasms*/Bone Neoplasms*/Bone Neoplasms*/pathology

• Source: Human cell [Hum Cell] 2024 Dec 09; Vol. 38 (1), pp. 29. Date of Electronic Publication: 2024 Dec 09.Publisher: Springer Country of Publication: Japan NLM ID: 8912329 Publication Model: Electronic Cited Medium: Internet ISSN: 1749-0774

Record details

Establishment and characterization of a novel patient-derived cell line from conventional central grade 3 chondrosarcoma, NCC-CS1-C1.

• Authors : Noguchi R; Division of Rare Cancer Research, National Cancer Center Research Institute, 5-1-1 Tsukiji, Chuo-Ku, Tokyo, 104-0045, Japan.; Ono T

Subjects: Chondrosarcoma*/Chondrosarcoma*/Chondrosarcoma*/pathology ; Chondrosarcoma*/Chondrosarcoma*/Chondrosarcoma*/genetics ; Bone Neoplasms*/Bone Neoplasms*/Bone Neoplasms*/pathology

• Source: Human cell [Hum Cell] 2024 Dec 08; Vol. 38 (1), pp. 28. Date of Electronic Publication: 2024 Dec 08.Publisher: Springer Country of Publication: Japan NLM ID: 8912329 Publication Model: Electronic Cited Medium: Internet ISSN: 1749-0774

Record details